Balaton A J, Nehama-Sibony M, Gotheil C, Callard P, Baviera E E
Service d'Anatomie et de Cytologie Pathologiques, Hôpital Saint Joseph, Paris, France.
J Pathol. 1988 Dec;156(4):305-10. doi: 10.1002/path.1711560405.
An antiserum to carcinoembryonic antigen (CEA) and a monoclonal antibody to cytokeratin 19 (CK 19) were studied for their suitability as diagnostic reagents for the differential diagnosis of primary and secondary malignant epithelial tumours of the liver, on paraffin sections. With the antiserum to CEA, positive bile canalicular structures were found in 60 per cent of the hepatocellular carcinomas. All the cholangiocarcinomas and 66.6 per cent of the metastatic carcinomas were positive for CEA, without displaying a canalicular staining pattern. All the hepatocellular carcinomas were negative for CK 19. All the cholangiocellular carcinomas and the metastatic carcinomas were positive for CK 19. This staining profile may prove helpful in difficult diagnostic cases.
研究了癌胚抗原(CEA)抗血清和细胞角蛋白19(CK 19)单克隆抗体作为石蜡切片上肝脏原发性和继发性恶性上皮肿瘤鉴别诊断诊断试剂的适用性。使用CEA抗血清时,60%的肝细胞癌中发现阳性胆小管结构。所有胆管癌和66.6%的转移癌CEA呈阳性,未表现出胆小管染色模式。所有肝细胞癌CK 19均为阴性。所有胆管细胞癌和转移癌CK 19均为阳性。这种染色特征可能有助于诊断困难的病例。